ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Stock Price Up 0.6% – Time to Buy?

by · The Markets Daily

Shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Get Free Report) rose 0.6% on Thursday . The stock traded as high as $51.69 and last traded at $51.09. Approximately 65,323 shares were traded during mid-day trading, an increase of 218% from the average daily volume of 20,543 shares. The stock had previously closed at $50.81.

ALPS Medical Breakthroughs ETF Trading Up 0.6%

The business’s 50-day moving average price is $45.33 and its 200-day moving average price is $37.49.

Institutional Trading of ALPS Medical Breakthroughs ETF

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Comerica Bank acquired a new stake in ALPS Medical Breakthroughs ETF during the 3rd quarter worth approximately $27,000. Raymond James Financial Inc. purchased a new stake in shares of ALPS Medical Breakthroughs ETF during the second quarter worth approximately $82,000. Ally Invest Advisors Inc. acquired a new stake in shares of ALPS Medical Breakthroughs ETF during the second quarter worth $200,000. Sterling Investment Advisors Ltd. purchased a new position in ALPS Medical Breakthroughs ETF in the 3rd quarter valued at $315,000. Finally, Moran Wealth Management LLC acquired a new position in ALPS Medical Breakthroughs ETF in the 2nd quarter valued at $300,000.

About ALPS Medical Breakthroughs ETF

(Get Free Report)

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.

Featured Articles